Current Issue

Apr 01, 2016
BioPharm International
Industry experts provide insights on the challenges and importance of using buffers in downstream processing.
Apr 01, 2016
BioPharm International
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
Apr 01, 2016
BioPharm International
Global outbreaks energize vaccine R&D and drive production modernization.
Apr 01, 2016
BioPharm International
The authors provide application data to support the use of SEC beyond small-scale operations.
Apr 01, 2016
BioPharm International
Proven science-based strategies can help to accelerate vaccine development.
Apr 01, 2016
BioPharm International
A modular cell-culture platform demonstrates accelerated process development.
Apr 01, 2016
BioPharm International
Selecting a delivery method early on may be beneficial.
Apr 01, 2016
BioPharm International
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing
Apr 01, 2016
BioPharm International
The author describes common components of a relative potency bioassay and provides a framework for assay development, calculation, and control.
Apr 01, 2016
BioPharm International
Careful planning, adequate staffing levels, and experienced project managers can help avoid pitfalls of transferring processes from one facility to another.
lorem ipsum